At risk for cervical cancer, Claudia Orozco’s cervical abnormalities were caught before they could progress at a See, Test & Treat program. The CAP Foundation's flagship program, See, Test & Treat is led by pathologists and provides free breast and cervical cancer screenings to underserved communities.

In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist. In this final part, Dr. Valenstein discusses what life was like the first six months after retiring.

In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist. In the second part, Dr. Valenstein addresses getting organized, making public declarations, economic transitions, electronic transitions, unwinding officially, saying goodbye, and planning for retired life.

In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist.

Unlike surgeons who can operate on tumors and internists who can manage a cluster of chronic conditions, the pathologist's core skill is the accurate use of words to describe a disease or a problem. Our scalpel is the correct taxonomy and our prescription is the pathology report. However, our words can have meaning only if the reader or listener can understand them and more importantly—trust them.

The recent decline in breast cancer mortality rates around the world is attributed to an increase in patient education, advances in breast imaging and screening and breast cancer therapy innovations. Despite all the advances made, early breast cancer detection, treatment and control have not equally benefitted all patient populations. Breast cancer patients who are African American suffer from a higher mortality rate compared to their white counterparts in the United States.

Recent advances and innovations in microscopic imaging technology are demonstrating the potential to significantly enhance the current clinical practice of diagnostic pathology.

Becoming a new attending in pathology is a transition into practice unlike that of any other specialty. These nine tips are a pathology-tailored version of personal management skills. The tips begin with how to gather objective performance data, the best advice I have on templates and creating a signing-out routine, and ending with mindset work, specifically ideas around self-awareness.

Labor crunches are not unique to pathology. Many, maybe all industries producing products and services experience them from time to time. However, savvy companies resolve their labor through innovation. Exemplary innovations that have surfaced over the last few decades include lean production, robotics and outsourcing. Maybe we can learn from them.

CAP has developed recommendations to aid adoption of the newly developed 2021 CKD-EPI-creatine equation for estimated glomerular filtration rate (eGFR). The new equation eliminates race-based adjustment factors that can delay recognition of chronic kidney disease (CKD), especially in Black/African American individuals.

The CAP's Digital Content Committee lists 10 tips and best practices to help physicians engage on social media.

The field of immuno-oncology (IO) continues to expand and evolve, delivering unprecedented clinical benefit to patients across a growing number of tumor types. However, IO therapies are not effective in all patients and can be associated with autoimmune side effects, which can be severe.

James Gill, MD, is a forensic pathologist, chief medical examiner of Connecticut, a clinical associate professor in pathology at Yale and chair of the College of American Pathologists (CAP) Forensic Pathology Committee. Dr. Gill answered questions about the ins and outs of forensic pathology and the experts of the field.

Each year, members of the Residents Forum are encouraged to apply for the Residents Forum Executive Committee. RFEC is charged with empowering members of the Residents Forum by providing a united representative voice inside of the College of American Pathologists’ Council on Membership and Professional Development (CMPD). RFEC is also responsible for ensuring member engagement, enhancing professional growth, and advancing pathology.

Large B-cell lymphomas are a heterogeneous group of aggressive non-Hodgkin lymphomas (NHL). Treatment responses and patient outcomes vary greatly between subtypes and depend on whether lymphomas occur de novo or as transformation of a preexisting low-grade lymphoma, on anatomic location, or on morphologic variant.

The US Supreme Court’s decision on Dobbs v. Jackson Women’s Health has far-reaching implications across the health care community for patients, health care providers, and health care plans. As pathologists and leaders in laboratory medicine, the CAP and its members stand with the physician community as it defends the practice of medicine and protects the sanctity of the patient-physician relationship.

The advances in radiographic techniques that enable precise targeting of lesions has revived attention to cytology specimens acquired by fine needle aspiration (FNA). One of the major advantages of FNA is that it is less invasive and better tolerated than a larger tissue biopsy and in many clinical scenarios provides sufficient material not only for morphological evaluation but also for ancillary studies including molecular testing. Accordingly, it is important to understand the pros and cons of molecular tests performed on cytological preparations.

The College of American Pathologists (CAP) strives for inclusivity and diversity in all our endeavors, and strongly supports gender-neutral blood donor screening based on individualized risk assessment for human immunodeficiency virus (HIV) infection instead of sexual orientation.

As the leading organization for pathologists, the CAP has a treasure trove of materials and subject matter experts who are dedicated to pathologist wellness.